Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neurogene (NGNE) Return on Sales (2018 - 2025)

Neurogene (NGNE) has disclosed Return on Sales for 5 consecutive years, with 1063.85% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Sales rose 101250.0% year-over-year to 1063.85%, compared with a TTM value of 1063.85% through Sep 2025, up 101250.0%, and an annual FY2024 reading of 80.16%, down 196088.0% over the prior year.
  • Return on Sales was 1063.85% for Q3 2025 at Neurogene, down from 23154.0% in the prior quarter.
  • Across five years, Return on Sales topped out at 23154.0% in Q2 2025 and bottomed at 28.34% in Q1 2024.